Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna, Inc. (MRNA) Presents at 35th Annual Piper Sandler Healthcare Conference (Transcript)
02:07pm, Thursday, 30'th Nov 2023
Moderna, Inc. (NASDAQ:MRNA ) 35th Annual Piper Sandler Healthcare Conference November 30, 2023 12:30 PM ET Company Participants Jamey Mock - CFO Conference Call Participants Ted Tenthoff - Piper Sandl
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
09:23am, Thursday, 30'th Nov 2023
The one thing that experts, along with vaccine makers, can agree on is that low vaccination rates put people at risk of getting severe Covid infections.
Moderna begins work on China mRNA manufacturing site
10:56pm, Monday, 27'th Nov 2023
U.S. vaccine maker Moderna began construction of its first facility in China this month to manufacture mRNA medicines, the company said on Tuesday.
BioNTech Vs. Moderna: Navigating The mRNA Landscape
07:55am, Wednesday, 22'nd Nov 2023
Moderna and BioNTech are pioneering companies in mRNA technology, known for their fast development of highly effective COVID-19 vaccines. Both companies have the potential to transform the treatment l
3 Biotech Stocks That Could Be Millionaire Makers
05:30am, Wednesday, 22'nd Nov 2023
There are several paths to millionaire status, and investing is one of them. But to give yourself a chance to become a millionaire this way, it's important to buy a diverse basket of solid companies a
BioNTech says European Patent Office has declared Moderna patent invalid
05:52am, Tuesday, 21'st Nov 2023
COVID-19 vaccine maker BioNTech said on Tuesday the European Patent Office has declared as invalid an mRNA patent that has been invoked by Moderna in litigation about alleged an patent violation by Bi
Don't Let the Q3 Earnings Miss Keep You From These 3 Stocks!
03:11pm, Monday, 20'th Nov 2023
Most of the earnings reports are in for the third quarter. But a contrarian play based on the results to date could actually be investment opportunities.
Moderna Nears Key Technical Level With Indications Of Reversal (Rating Upgrade)
02:51am, Monday, 20'th Nov 2023
Moderna experienced a significant decline in Q3 2023 revenue, primarily due to a slump in COVID-19 vaccine sales. The company incurred substantial costs, including inventory write-downs and manufactur
Investing In Moderna: A Calculated Risk Worth Taking For Patient Investors
12:32am, Monday, 20'th Nov 2023
Moderna reported $1.8 billion in revenue, beating estimates, but recorded a massive GAAP earnings-per-share loss. Wall Street analysts lowered price targets for Moderna stock following the lackluster
Moderna, Inc. (MRNA) Second Digital Investor Event Transcript
11:45am, Saturday, 11'th Nov 2023
Moderna, Inc. (NASDAQ:MRNA ) Second Digital Investor Event November 8, 2023 8:00 AM ET Company Participants Lavina Talukdar - Head of IR Stephane Bancel - CEO Brad Miller - Chief Information Officer D
Why Moderna Stock Was Cratering This Week
06:29am, Friday, 10'th Nov 2023
Several analysts cut their price targets on the once-hotly popular biotech. Moderna is known for its Spikevax coronavirus vaccine.
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.
08:45am, Thursday, 09'th Nov 2023
Moderna's stock hasn't done well lately now that coronavirus vaccine sales are falling. But the biotech has an ambitious plan to launch over a dozen medicines relatively soon.
Moderna to Present at Upcoming Conferences in November 2023
04:15pm, Wednesday, 08'th Nov 2023
CAMBRIDGE, MA / ACCESSWIRE / November 8, 2023 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: 2023 UBS Global Biopharma Conference on N
6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%
12:16pm, Wednesday, 08'th Nov 2023
One knock against Wall Street analysts is they're too bullish, especially when it comes to Nasdaq 100 stocks. No matter the market conditions, they seem able to find the silver lining.
High Risk Alert: 7 Vulnerable Stocks to Dump Now
01:06pm, Tuesday, 07'th Nov 2023
Investors face a complicated picture heading into the holiday season. War, inflation, high interest rates, and a potential recession are among the risk factors on the horizon.
